Company Data

Puma Biotechnology Inc

Ticker
PBYI
Current Price
$4.955 -0.3%
Market Cap
$249.6M
Price Target
Refer to Report
Volume
176.9K
52wk Range
$2.225 - $6.07
Advanced Market Data

Overview

Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy